Roche Holding AG
RHO
Company Profile
Business description
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Contact
Grenzacherstrasse 124
Basel4070
CHET: +41 616881111
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
103,249
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,757.90 | 13.20 | -0.15% |
| CAC 40 | 7,697.54 | 13.81 | 0.18% |
| DAX 40 | 23,453.24 | 18.59 | 0.08% |
| Dow JONES (US) | 42,215.80 | 299.29 | -0.70% |
| FTSE 100 | 8,849.47 | 15.44 | 0.17% |
| HKSE | 23,710.69 | 269.61 | -1.12% |
| NASDAQ | 19,521.09 | 180.12 | -0.91% |
| Nikkei 225 | 38,885.15 | 348.41 | 0.90% |
| NZX 50 Index | 12,627.32 | 12.03 | -0.10% |
| S&P 500 | 5,982.72 | 50.39 | -0.84% |
| S&P/ASX 200 | 8,531.20 | 10.10 | -0.12% |
| SSE Composite Index | 3,388.81 | 1.40 | 0.04% |